DXR Q4 2021 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena

DXRDaxor Corporation

$58M

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$152,438+4.8% YoY

Gross Profit

$152,438100.0% margin

Operating Income

-$448,994-294.5% margin

Net Income

$6M4130.8% margin

EPS (Diluted)

$0.78

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$181,285

Balance Sheet

Total Assets

$25M

Total Liabilities

$4M

Stockholders' Equity

$21M

Cash & Equivalents

$710,700

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$152,438	$145,492	+4.8%
Gross Profit	$152,438	$145,492	+4.8%
Operating Income	-$448,994	-$234,194	-91.7%
Net Income	$6M	$2M	+241.7%